Milatuzumab
Encyclopedia
Milatuzumab is a monoclonal antibody for the treatment of multiple myeloma
and other hematological malignancies.
This drug was developed by Immunomedics, Inc.
It has been linked to doxorubicin
to form an antibody-drug conjugate
for treatment of relapsed multiple myeloma
. A phase I/II clinical trial has started.
Multiple myeloma
Multiple myeloma , also known as plasma cell myeloma or Kahler's disease , is a cancer of plasma cells, a type of white blood cell normally responsible for the production of antibodies...
and other hematological malignancies.
This drug was developed by Immunomedics, Inc.
It has been linked to doxorubicin
Doxorubicin
Doxorubicin INN is a drug used in cancer chemotherapy. It is an anthracycline antibiotic, closely related to the natural product daunomycin, and like all anthracyclines, it works by intercalating DNA....
to form an antibody-drug conjugate
Antibody-drug conjugate
Antibody-drug conjugates are a new type of targeted therapy, used for example for cancer. They consist of an antibody linked to a payload drug . Hence, they are a type of immunoconjugate and often an immunotoxin.The antibody causes the ADC to bind to the target cancer cells...
for treatment of relapsed multiple myeloma
Multiple myeloma
Multiple myeloma , also known as plasma cell myeloma or Kahler's disease , is a cancer of plasma cells, a type of white blood cell normally responsible for the production of antibodies...
. A phase I/II clinical trial has started.